“…The performance of these particles as adjuvants is usually determined by their intrinsic characteristics, such as size [ 52 , 53 , 54 ], shape [ 55 , 56 ], surface charge [ 57 ], and hydrophobicity [ 58 , 59 ], and also are influenced by the methods used for antigen loading [ 60 ], the density of antigen on the surface [ 61 ], the ability of controlled-release kinetics [ 62 ], functionalization [ 63 , 64 , 65 ], and importantly mucoadhesion [ 66 , 67 ]. In many cases, particulate vaccine adjuvants mimic the size, shape, and surface molecule organization of pathogenic microorganisms and can contain molecules such as pathogen-associated molecular patterns, which directly impact the recognition, interaction, phagocytosis, and processing of antigens by antigen-presenting cells (APCs), affecting vaccine efficacy [ 68 , 69 , 70 ].…”